Last reviewed · How we verify
Topiramate and N-Acetyl Cysteine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Topiramate and N-Acetyl Cysteine (Topiramate and N-Acetyl Cysteine) — Nassima Ait-Daoud Tiouririne.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Topiramate and N-Acetyl Cysteine TARGET | Topiramate and N-Acetyl Cysteine | Nassima Ait-Daoud Tiouririne | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Topiramate and N-Acetyl Cysteine CI watch — RSS
- Topiramate and N-Acetyl Cysteine CI watch — Atom
- Topiramate and N-Acetyl Cysteine CI watch — JSON
- Topiramate and N-Acetyl Cysteine alone — RSS
Cite this brief
Drug Landscape (2026). Topiramate and N-Acetyl Cysteine — Competitive Intelligence Brief. https://druglandscape.com/ci/topiramate-and-n-acetyl-cysteine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab